Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
DEL PRIS
SecurityDE:10V / Immunic, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership263,328 shares
Latest Disclosed Value $ 292,294
Northern Trust Corp reports 19.30% increase in ownership of 10V / Immunic, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 263,328 shares of Immunic, Inc. (DE:10V) valued at $292,294 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 220,727 shares of Immunic, Inc.. This represents a change in shares of 19.30% during the quarter. The current value of the position is $4,379,671 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F IMMUNIC COM 4525EP101 263,328 42,601 19.30 292 149.57 0.0000
2026-02-17 2025-12-31 13F IMMUNIC COM 4525EP101 220,727 9,380 4.44 118 -37.10 0.0000
2025-11-14 2025-09-30 13F IMMUNIC COM 4525EP101 211,347 -46,972 -18.18 186 3.33 0.0000
2025-08-13 2025-06-30 13F IMMUNIC COM 4525EP101 258,319 27,101 11.72 180 -28.57 0.0000
2025-05-13 2025-03-31 13F IMMUNIC COM 4525EP101 231,218 0 0.00 252 9.09 0.0000
2025-02-14 2024-12-31 13F IMMUNIC COM 4525EP101 231,218 -367 -0.16 231 -39.53 0.0000
2024-11-13 2024-09-30 13F IMMUNIC COM 4525EP101 231,585 -33,383 -12.60 382 29.93 0.0001
2024-08-14 2024-06-30 13F IMMUNIC COM 4525EP101 264,968 24,730 10.29 294 -7.26 0.0000
2024-05-14 2024-03-31 13F IMMUNIC COM 4525EP101 240,238 75,799 46.10 317 28.86 0.0001
2024-02-13 2023-12-31 13F IMMUNIC COM 4525EP101 164,439 54,225 49.20 247 51.85 0.0000
2023-11-13 2023-09-30 13F IMMUNIC COM 4525EP101 110,214 -374 -0.34 162 -41.52 0.0000
2023-08-11 2023-06-30 13F IMMUNIC COM 4525EP101 110,588 12,880 13.18 278 91.03 0.0001
2023-05-15 2023-03-31 13F IMMUNIC COM 4525EP101 97,708 16,254 19.95 146 27.19 0.0000
2023-02-13 2022-12-31 13F IMMUNIC COM 4525EP101 81,454 1,106 1.38 114 -55.12 0.0000
2022-11-14 2022-09-30 13F IMMUNIC COM 4525EP101 80,348 4,576 6.04 254 -3.42 0.0001
2022-08-12 2022-06-30 13F IMMUNIC COM 4525EP101 75,772 -112,376 -59.73 263 -87.63 0.0001
2022-05-13 2022-03-31 13F IMMUNIC COM 4525EP101 188,148 5,553 3.04 2,126 21.62 0.0004
2022-02-08 2021-12-31 13F IMMUNIC COM 4525EP101 182,595 728 0.40 1,748 8.57 0.0003
2021-11-15 2021-09-30 13F IMMUNIC COM 4525EP101 181,867 16,578 10.03 1,610 -20.53 0.0003
2021-08-13 2021-06-30 13F IMMUNIC COM 4525EP101 165,289 65,032 64.87 2,026 26.78 0.0004
2021-05-12 2021-03-31 13F IMMUNIC COM 4525EP101 100,257 -16,886 -14.41 1,598 -10.78 0.0003
2021-02-11 2020-12-31 13F IMMUNIC COM 4525EP101 117,143 -5,074 -4.15 1,791 -21.10 0.0003
2020-11-16 2020-09-30 13F IMMUNIC COM 4525EP101 122,217 41,499 51.41 2,270 131.87 0.0005
2020-08-14 2020-06-30 13F IMMUNIC COM 4525EP101 80,718 80,718 979 0.0002
2019-08-12 2019-06-30 13F VITAL THERAPIES COM 92847R104 0 -350,876 -100.00 0 -100.00
2019-05-13 2019-03-31 13F VITAL THERAPIES COM 92847R104 350,876 -22,797 -6.10 69 0.00 0.0000
2019-02-12 2018-12-31 13F VITAL THERAPIES COM 92847R104 373,673 7,676 2.10 69 -31.00 0.0000
2018-11-14 2018-09-30 13F VITAL THERAPIES COM 92847R104 365,997 231,927 172.99 100 -89.12 0.0000
2018-09-18 2018-06-30 13F/A-1 VITAL THERAPIES COM 92847R104 134,070 50,382 60.20 919 61.51 0.0002
2018-08-14 2018-06-30 13F VITAL THERAPIES COM 92847R104 134,070 50,382 919
2018-05-09 2018-03-31 13F VITAL THERAPIES COM 92847R104 83,688 8,993 12.04 569 28.15 0.0001
2018-02-14 2017-12-31 13F VITAL THERAPIES COM 92847R104 74,695 -6,388 -7.88 444 8.29 0.0001
2017-11-13 2017-09-30 13F VITAL THERAPIES COM 92847R104 81,083 25,960 47.09 410 156.25 0.0001
2017-08-11 2017-06-30 13F VITAL THERAPIES COM 92847R104 55,123 -205,891 -78.88 160 -84.67 0.0000
2017-05-12 2017-03-31 13F VITAL THERAPIES COM 92847R104 261,014 -4,370 -1.65 1,044 -9.53 0.0003
2017-02-13 2016-12-31 13F VITAL THERAPIES COM 92847R104 265,384 -8,072 -2.95 1,154 -31.06 0.0004
2016-11-09 2016-09-30 13F VITAL THERAPIES COM 92847R104 273,456 -8,416 -2.99 1,674 -4.18 0.0005
2016-08-12 2016-06-30 13F VITAL THERAPIES COM 92847R104 281,872 31,313 12.50 1,747 -23.14 0.0006
2016-08-19 2016-03-31 13F/A-1 VITAL THERAPIES COM 92847R104 250,559 3,898 1.58 2,273 -20.02 0.0008
2016-05-13 2016-03-31 13F VITAL THERAPIES COM 92847R104 250,559 2,273
2016-02-12 2015-12-31 13F VITAL THERAPIES COM 92847R104 246,661 55,395 28.96 2,842 267.66 0.0009
2015-11-12 2015-09-30 13F VITAL THERAPIES COM 92847R104 191,266 191,266 0.00 773 0.0003
2015-08-13 2015-06-30 13F VITAL THERAPIES COM 92847R104 0 -69,533 -100.00 0 -100.00
2015-05-14 2015-03-31 13F VITAL THERAPIES COM 92847R104 69,533 8,972 14.81 1,739 15.17 0.0005
2015-02-12 2014-12-31 13F VITAL THERAPIES COM 92847R104 60,561 6,520 12.06 1,510 36.90 0.0005
2014-11-13 2014-09-30 13F VITAL THERAPIES COM 92847R104 54,041 41,278 323.42 1,103 216.95 0.0003
2014-08-14 2014-06-30 13F VITAL THERAPIES COM 92847R104 12,763 12,763 348 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.